Life Sciences
At HIMSS26, Verily Life Sciences announced a partnership with Samsung Electronics to combine Galaxy Watch8 with Verily's precision health platform to further clinical research.
General Catalyst's Dr. Stephen Klasko says he's launched a medical education program that integrates AI and data literacy and chooses students based on communication skills, empathy and cultural competence rather than test scores.
Mount Sinai Health System, Nvidia and ARC Innovation Center leaders describe how their collaboration aims to decode the human genome using AI in order to more precisely predict disease risk and understand individual therapy response.
A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
For his upcoming HIMSS26 presentation, ChristianaCare's Greg O'Neill discusses how practical tools like plain language, pictograms, multilingual translation and tailored discharge instructions can boost medication compliance.
Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.
Emerging Technologies
Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.